nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofedanol—Amitriptyline—migraine	0.555	1	CrCtD
Clofedanol—HRH1—Amitriptyline—migraine	0.0673	1	CbGbCtD
Clofedanol—Aprindine—Amitriptyline—migraine	0.0437	0.121	CrCrCtD
Clofedanol—Doxepin—Amitriptyline—migraine	0.0243	0.0671	CrCrCtD
Clofedanol—Cyclobenzaprine—Amitriptyline—migraine	0.0228	0.0631	CrCrCtD
Clofedanol—Dimetindene—Amitriptyline—migraine	0.0222	0.0612	CrCrCtD
Clofedanol—Doxylamine—Amitriptyline—migraine	0.021	0.058	CrCrCtD
Clofedanol—Tripelennamine—Amitriptyline—migraine	0.019	0.0524	CrCrCtD
Clofedanol—Trimipramine—Amitriptyline—migraine	0.0185	0.0512	CrCrCtD
Clofedanol—Clomipramine—Amitriptyline—migraine	0.0181	0.0501	CrCrCtD
Clofedanol—Bromodiphenhydramine—Amitriptyline—migraine	0.0177	0.049	CrCrCtD
Clofedanol—Dimetacrine—Amitriptyline—migraine	0.0177	0.049	CrCrCtD
Clofedanol—Pheniramine—Amitriptyline—migraine	0.0174	0.048	CrCrCtD
Clofedanol—Imipramine—Amitriptyline—migraine	0.017	0.047	CrCrCtD
Clofedanol—Chlorprothixene—Amitriptyline—migraine	0.017	0.047	CrCrCtD
Clofedanol—Promethazine—Amitriptyline—migraine	0.0157	0.0435	CrCrCtD
Clofedanol—Alimemazine—Amitriptyline—migraine	0.0154	0.0427	CrCrCtD
Clofedanol—Atomoxetine—Propranolol—migraine	0.0148	0.0408	CrCrCtD
Clofedanol—Orphenadrine—Amitriptyline—migraine	0.0139	0.0385	CrCrCtD
Clofedanol—Promazine—Amitriptyline—migraine	0.0133	0.0368	CrCrCtD
Clofedanol—Diphenhydramine—Amitriptyline—migraine	0.0124	0.0342	CrCrCtD
Clofedanol—HRH1—Monoamine GPCRs—HTR1D—migraine	0.000791	0.066	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR2B—migraine	0.000736	0.0613	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR1D—migraine	0.000665	0.0555	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR2B—migraine	0.000618	0.0516	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR1B—migraine	0.000479	0.04	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR1A—migraine	0.000461	0.0385	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR2C—migraine	0.000446	0.0372	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR1B—migraine	0.000403	0.0336	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR7—migraine	0.00039	0.0325	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR1A—migraine	0.000388	0.0323	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR2C—migraine	0.000375	0.0312	CbGpPWpGaD
Clofedanol—Loperamide—CACNA1A—migraine	0.000346	0.0979	CrCbGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR7—migraine	0.000328	0.0274	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR2A—migraine	0.000273	0.0228	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR2A—migraine	0.00023	0.0192	CbGpPWpGaD
Clofedanol—Alverine—HTR1A—migraine	0.000203	0.0576	CrCbGaD
Clofedanol—HRH1—G alpha (q) signalling events—HTR2B—migraine	0.000184	0.0153	CbGpPWpGaD
Clofedanol—Captodiame—HTR2C—migraine	0.000166	0.0469	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000164	0.0137	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000153	0.0127	CbGpPWpGaD
Clofedanol—HRH1—IL-4 Signaling Pathway—FOS—migraine	0.000147	0.0123	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000142	0.0118	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—RAMP1—migraine	0.000137	0.0114	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CALCRL—migraine	0.000137	0.0114	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000131	0.0109	CbGpPWpGaD
Clofedanol—Atomoxetine—HTR1D—migraine	0.00013	0.0367	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000122	0.0101	CbGpPWpGaD
Clofedanol—Toremifene—ESR1—migraine	0.000121	0.0342	CrCbGaD
Clofedanol—Orphenadrine—SCN1A—migraine	0.00012	0.0339	CrCbGaD
Clofedanol—Clomipramine—HTR2B—migraine	0.000115	0.0325	CrCbGaD
Clofedanol—Chlorprothixene—HTR2B—migraine	0.000114	0.0323	CrCbGaD
Clofedanol—HRH1—G alpha (q) signalling events—NPS—migraine	0.000113	0.00946	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—TAC1—migraine	0.000113	0.00946	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—HTR2C—migraine	0.000111	0.00928	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—EDNRA—migraine	0.000108	0.00902	CbGpPWpGaD
Clofedanol—Trimipramine—HTR3A—migraine	0.000108	0.0305	CrCbGaD
Clofedanol—Trimipramine—HTR1D—migraine	0.000107	0.0302	CrCbGaD
Clofedanol—Methadone—HTR3A—migraine	0.000102	0.0289	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000101	0.00846	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000101	0.00846	CbGpPWpGaD
Clofedanol—Doxepin—HTR2B—migraine	0.000101	0.0285	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—HTR1D—migraine	9.96e-05	0.00831	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	9.95e-05	0.0083	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	9.68e-05	0.00807	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR2B—migraine	9.26e-05	0.00772	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.25e-05	0.00771	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.9e-05	0.00743	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.6e-05	0.00717	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.37e-05	0.00698	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.93e-05	0.00661	CbGpPWpGaD
Clofedanol—Chlorpromazine—HTR2B—migraine	7.87e-05	0.0223	CrCbGaD
Clofedanol—Amitriptyline—HTR1D—migraine	7.86e-05	0.0223	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—RAMP1—migraine	7.75e-05	0.00646	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CALCRL—migraine	7.75e-05	0.00646	CbGpPWpGaD
Clofedanol—Atomoxetine—HTR1B—migraine	7.69e-05	0.0218	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.63e-05	0.00636	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.53e-05	0.00628	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.51e-05	0.00627	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.51e-05	0.00627	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.37e-05	0.00614	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.17e-05	0.00598	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—RAMP1—migraine	7.04e-05	0.00587	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CALCRL—migraine	7.04e-05	0.00587	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—HTR2A—migraine	6.83e-05	0.00569	CbGpPWpGaD
Clofedanol—Cyclobenzaprine—HTR2A—migraine	6.8e-05	0.0192	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.45e-05	0.00538	CbGpPWpGaD
Clofedanol—Atomoxetine—HTR2C—migraine	6.27e-05	0.0178	CrCbGaD
Clofedanol—Chlorphenamine—SLC6A4—migraine	6.18e-05	0.0175	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	6.1e-05	0.00509	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR1B—migraine	6.04e-05	0.00503	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR1A—migraine	5.81e-05	0.00484	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—NPS—migraine	5.72e-05	0.00477	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—TAC1—migraine	5.72e-05	0.00477	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR1D—migraine	5.63e-05	0.00469	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR2C—migraine	5.61e-05	0.00468	CbGpPWpGaD
Clofedanol—Clomipramine—HTR2C—migraine	5.61e-05	0.0159	CrCbGaD
Clofedanol—Chlorprothixene—HTR2C—migraine	5.58e-05	0.0158	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—EDNRA—migraine	5.46e-05	0.00455	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.28e-05	0.0044	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CALCA—migraine	5.25e-05	0.00438	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR2B—migraine	5.23e-05	0.00436	CbGpPWpGaD
Clofedanol—Atomoxetine—SLC6A4—migraine	5.2e-05	0.0147	CrCbGaD
Clofedanol—Trimipramine—HTR2C—migraine	5.16e-05	0.0146	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HTR1D—migraine	5.11e-05	0.00426	CbGpPWpGaD
Clofedanol—Trimipramine—HTR1A—migraine	5.01e-05	0.0142	CrCbGaD
Clofedanol—Doxepin—HTR2C—migraine	4.92e-05	0.0139	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—HTR7—migraine	4.91e-05	0.0041	CbGpPWpGaD
Clofedanol—Chlorpromazine—HTR7—migraine	4.87e-05	0.0138	CrCbGaD
Clofedanol—Imipramine—HTR7—migraine	4.84e-05	0.0137	CrCbGaD
Clofedanol—Tamoxifen—ESR1—migraine	4.83e-05	0.0137	CrCbGaD
Clofedanol—Amitriptyline—HTR7—migraine	4.81e-05	0.0136	CrCbGaD
Clofedanol—Doxepin—HTR1A—migraine	4.77e-05	0.0135	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HTR2B—migraine	4.75e-05	0.00396	CbGpPWpGaD
Clofedanol—Amitriptyline—HTR1B—migraine	4.66e-05	0.0132	CrCbGaD
Clofedanol—Clomipramine—SLC6A4—migraine	4.64e-05	0.0132	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.52e-05	0.00377	CbGpPWpGaD
Clofedanol—Promazine—HTR2C—migraine	4.37e-05	0.0124	CrCbGaD
Clofedanol—Trimipramine—SLC6A4—migraine	4.27e-05	0.0121	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—CALCRL—migraine	4.16e-05	0.00347	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—RAMP1—migraine	4.16e-05	0.00347	CbGpPWpGaD
Clofedanol—Doxepin—SLC6A4—migraine	4.07e-05	0.0115	CrCbGaD
Clofedanol—Atomoxetine—HTR2A—migraine	3.99e-05	0.0113	CrCbGaD
Clofedanol—Chlorpromazine—HTR2C—migraine	3.84e-05	0.0109	CrCbGaD
Clofedanol—Imipramine—HTR2C—migraine	3.82e-05	0.0108	CrCbGaD
Clofedanol—Amitriptyline—HTR2C—migraine	3.8e-05	0.0108	CrCbGaD
Clofedanol—Chlorpromazine—HTR1A—migraine	3.73e-05	0.0106	CrCbGaD
Clofedanol—Imipramine—HTR1A—migraine	3.71e-05	0.0105	CrCbGaD
Clofedanol—Amitriptyline—HTR1A—migraine	3.69e-05	0.0104	CrCbGaD
Clofedanol—Clomipramine—HTR2A—migraine	3.57e-05	0.0101	CrCbGaD
Clofedanol—Chlorprothixene—HTR2A—migraine	3.55e-05	0.0101	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—HTR2A—migraine	3.44e-05	0.00287	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR1B—migraine	3.41e-05	0.00284	CbGpPWpGaD
Clofedanol—Trimipramine—HTR2A—migraine	3.28e-05	0.0093	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR1A—migraine	3.28e-05	0.00274	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—TAC1—migraine	3.23e-05	0.0027	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—NPS—migraine	3.23e-05	0.0027	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR2C—migraine	3.17e-05	0.00264	CbGpPWpGaD
Clofedanol—Imipramine—SLC6A4—migraine	3.17e-05	0.00898	CrCbGaD
Clofedanol—Promethazine—HTR2A—migraine	3.16e-05	0.00896	CrCbGaD
Clofedanol—Amitriptyline—SLC6A4—migraine	3.15e-05	0.00892	CrCbGaD
Clofedanol—Doxepin—HTR2A—migraine	3.13e-05	0.00886	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HTR1B—migraine	3.1e-05	0.00258	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—EDNRA—migraine	3.08e-05	0.00257	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR1D—migraine	3.02e-05	0.00252	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—HTR1A—migraine	2.98e-05	0.00249	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CALCA—migraine	2.97e-05	0.00248	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—TAC1—migraine	2.94e-05	0.00245	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NPS—migraine	2.94e-05	0.00245	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—HTR2C—migraine	2.88e-05	0.0024	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR2B—migraine	2.81e-05	0.00234	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—EDNRA—migraine	2.8e-05	0.00234	CbGpPWpGaD
Clofedanol—Promazine—HTR2A—migraine	2.78e-05	0.00788	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR7—migraine	2.78e-05	0.00232	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CALCA—migraine	2.7e-05	0.00225	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—HTR7—migraine	2.52e-05	0.0021	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—LRP1—migraine	2.47e-05	0.00206	CbGpPWpGaD
Clofedanol—Chlorpromazine—HTR2A—migraine	2.45e-05	0.00693	CrCbGaD
Clofedanol—Imipramine—HTR2A—migraine	2.44e-05	0.0069	CrCbGaD
Clofedanol—Amitriptyline—HTR2A—migraine	2.42e-05	0.00685	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR2A—migraine	1.95e-05	0.00162	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NOTCH4—migraine	1.9e-05	0.00158	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR1B—migraine	1.83e-05	0.00153	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—HTR2A—migraine	1.77e-05	0.00147	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR1A—migraine	1.76e-05	0.00147	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NPS—migraine	1.73e-05	0.00145	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PGR—migraine	1.73e-05	0.00145	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—TAC1—migraine	1.73e-05	0.00145	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR2C—migraine	1.7e-05	0.00142	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—EDNRA—migraine	1.65e-05	0.00138	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NOTCH3—migraine	1.61e-05	0.00134	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CALCA—migraine	1.59e-05	0.00133	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR7—migraine	1.49e-05	0.00124	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—TGFBR2—migraine	1.28e-05	0.00107	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR2A—migraine	1.04e-05	0.00087	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ESR1—migraine	9.26e-06	0.000772	CbGpPWpGaD
